P47 Prevalence, incidence and patterns of antiasthma medication use in children: a nationwide prescription study in France

التفاصيل البيبلوغرافية
العنوان: P47 Prevalence, incidence and patterns of antiasthma medication use in children: a nationwide prescription study in France
المؤلفون: I Naim, Y. De Rycke, Aya Ajrouche, S. Guillo, Florence Tubach, Florentia Kaguelidou
المصدر: Archives of Disease in Childhood. 104:e36.2-e36
بيانات النشر: BMJ, 2019.
سنة النشر: 2019
مصطلحات موضوعية: medicine.medical_specialty, Medication use, business.industry, Incidence (epidemiology), medicine.disease, Prevalence incidence, Drug dispensing, Pediatrics, Perinatology and Child Health, Epidemiology, medicine, Antiasthmatic drugs, Medical prescription, business, Demography, Asthma
الوصف: BackgroundUse of antiasthmatic medications has increased over the years worldwide. The aim of this study was to describe the use of antiasthmatic drugs in children in France.MethodsData were retrieved from the permanent sample (1/97th) of the French national healthcare database - the Système National des Données de Santé (SNDS) for all individuals aged from 5 to 18 years old (n=143,909) from 1 January 2011 to 31 December 2017. Prevalence and incidence rate of antiasthmatic dispensing were calculated. All analyses were stratified by calendar year, age (5–11, 12–18 years) and gender. Users were classified as occasional if they had only one dispensing of antiasthmatic drugs over the year, moderate and high if they had antiasthmatic drug dispensing at two distinct occasions or at three or more occasions, respectively.ResultsThe annual prevalence of antiasthmatic drug use varied between 12 (2011) and 11 (2017) per 100 persons and incidence varied between 4.3 (2013) and 3.8 (2017) per 100 PYs. Prevalence and incidence of use were higher in children aged between 5–11 years compared to adolescents and in boys compared to girls. Most users were occasional (52%) and only one third redeemed prescriptions on a regular basis (high users: 30%). No trend was observed regarding these percentages over time or with gender and age group.ConclusionsUse of antiasthmatic drugs in France is higher than previously described in other European countries. Prevalence of use is also higher than the prevalence of asthma as assessed in epidemiological national studies suggesting that these drugs are over-prescribed.Disclosure(s)Nothing to disclose
تدمد: 1468-2044
0003-9888
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_________::d70b418c076ea55e95e3dc53097a6fcdTest
https://doi.org/10.1136/archdischild-2019-esdppp.85Test
حقوق: OPEN
رقم الانضمام: edsair.doi...........d70b418c076ea55e95e3dc53097a6fcd
قاعدة البيانات: OpenAIRE